Kardiomiopatia połogowa – aktualny stan wiedzy Artykuł przeglądowy
##plugins.themes.bootstrap3.article.sidebar##
Opublikowane:
wrz 30, 2013
Słowa kluczowe:
kardiomiopatia połogowa, ciąża, niewydolność serca
##plugins.themes.bootstrap3.article.main##
Abstrakt
Kardiomiopatia połogowa, zwana inaczej kardiomiopatią w czasie połogu, jest jedną z rzadkich przyczyn niewydolności serca występującą u kobiet pod koniec ciąży lub we wczesnym okresie połogu. W artykule opisano aktualny stan wiedzy na temat kardiomiopatii połogowej, jej epidemiologię, etiologię, czynniki ryzyka, obraz kliniczny, metody rozpoznawania, leczenia i rokowanie.
Pobrania
Dane pobrania nie są jeszcze dostepne
##plugins.themes.bootstrap3.article.details##
Jak cytować
Możeńska , O., Kalińska , I., & Kosior , D. A. (2013). Kardiomiopatia połogowa – aktualny stan wiedzy . Kardiologia W Praktyce, 7(3), 10-21. Pobrano z https://journalsmededu.pl/index.php/kwp/article/view/1559
Numer
Dział
Artykuły
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa – Użycie niekomercyjne – Bez utworów zależnych 4.0 Międzynarodowe.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
Bibliografia
1. Richie C.: Clinical contribution to the pathology, diagnosis and treatment of certain chronic diseases of the heart. Edinb. Med. Surg. J. 1849, 2: 333.
2. Hull E., Hafkesbring E.: Toxic postpartal heart disease. New Orleans Med. Surg. J. 1937, 89: 550.
3. Sliwa K., Fett J., Elkayam U.: Peripartum cardiomyopathy. Lancet 2006, 368(9536): 687-693.
4. Demakis J.G., Rahimtoola S.H., Sutton G.C., Meadows W.R., Szanto P.B., Tobin J.R., Gunnar R.M.: Natural course of peripartum cardiomyopathy. Circulation 1971, 44(6): 1053-1061.
5. Pearson G.D., Veille J.C., Rahimtoola S., Hsia J., Oakley C.M., Hosenpud J.D., Ansari A., Baughman K.L.: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000, 283(9): 1183-1188.
6. Hibbard J.U., Lindheimer M., Lang R.M.: A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstetrics and Gynecology 1999, 94(2): 311-316.
7. Elkayam U., Akhter M.W., Singh H., Khan S., Bitar F., Hameed A., Shotan A.: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111(16): 2050-2055.
8. Seftel H., Susser M.: Maternity and myocardial failure in African women. British Heart Journal 1961, 23: 43-52.
9. Davidson N.M., Parry E.H.: The etiology of peripartum cardiac failure. American Heart Journal 1979, 97(4): 535-536.
10. Woolford R.M.: Postpartum myocardosis. Ohio medicine: journal of the Ohio State Medical Association 1952, 48(10): 924-930.
11. Pierce J.A., Price B.O., Joyce J.W.: Familial occurrence of postpartal heart failure. Archives of Internal Medicine 1963, 111: 651-655.
12. Sliwa K., Damasceno A., Mayosi B.M.: Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005, 112(23): 3577-3583.
13. Lampert M.B., Lang R.M.: Peripartum cardiomyopathy. American Heart Journal 1995, 130(4): 860-870.
14. Fett J.D., Christie L.G., Carraway R.D., Murphy J.G.: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clinic proceedings Mayo Clinic 2005, 80(12): 1602-1606.
15. King T.M., Whitehorn W.V., Reeves B., Kubota R.: Effects of estrogen on composition and function of cardiac muscle. The American Journal of Physiology 1959, 196(6): 1282-1285.
16. Ueland K., Parer J.T.: Effects of estrogens on the cardiovascular system of the ewe. American Journal of Obstetrics and Gynecology 1966, 96(3): 400-406.
17. Schaible T.F., Malhotra A., Ciambrone G., Scheuer J.: The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circulation Research 1984, 54(1): 38-49.
18. Bryant E.E., Douglas B.H., Ashburn A.D.: Circulatory changes following prolactin administration. American Journal of Obstetrics and Gynecology 1973, 115(1): 53-57.
19. Sliwa K., Skudicky D., Bergemann A., Candy G., Puren A., Sareli P.: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. Journal of the American College of Cardiology 2000, 35(3): 701-705.
20. Sliwa K., Forster O., Libhaber E., Fett J.D., Sundstrom J.B., Hilfiker-Kleiner D., Ansari A.A.: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. European Heart Journal 2006, 27(4): 441-446.
21. Hilfiker-Kleiner D., Kaminski K., Podewski E., Bonda T., Schaefer A., Sliwa K., Forster O., Quint A., Landmesser U., Doerries C. et al.: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128(3): 589-600.
22. Melvin K.R., Richardson P.J., Olsen E.G., Daly K., Jackson G.: Peripartum cardiomyopathy due to myocarditis. N. Engl. J. Med. 1982, 307(12): 731-734.
23. Sanderson J.E., Olsen E.G., Gatei D.: Peripartum heart disease: an endomyocardial biopsy study. British Heart Journal 1986, 56(3): 285-291.
24. O’Connell J.B., Costanzo-Nordin M.R., Subramanian R., Robinson J.A., Wallis D.E., Scanlon P.J., Gunnar R.M.: Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. Journal of the American College of Cardiology 1986, 8(1): 52-56.
25. Midei M.G., DeMent S.H., Feldman A.M., Hutchins G.M., Baughman K.L.: Peripartum myocarditis and cardiomyopathy. Circulation 1990, 81(3): 922-928.
26. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., Kandolf R.: High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. American Journal of Obstetrics and Gynecology 2005, 193(2): 363-365.
27. Rizeq M.N., Rickenbacher P.R., Fowler M.B., Billingham M.E.: Incidence of myocarditis in peripartum cardiomyopathy. The American Journal of Cardiology 1994, 74(5): 474-477.
28. Nelson J.L.: Pregnancy, persistent microchimerism, and autoimmune disease. Journal of the American Medical Women’s Association 1998, 53(1): 31-32, 47.
29. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., Sundstrom J.B.: Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clinical Reviews in Allergy & Immunology 2002, 23(3): 301-324.
30. Cenac A., Beaufils H., Soumana I., Vetter J.M., Devillechabrolle A., Moulias R.: Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. International Journal of Cardiology 1990, 26(1): 49-52.
31. Pearl W.: Familial occurrence of peripartum cardiomyopathy. American Heart Journal 1995, 129(2): 421-422.
32. van Spaendonck-Zwarts K.Y., van Tintelen J.P., van Veldhuisen D.J., van der Werf R., Jongbloed J.D., Paulus W.J., Dooijes D., van den Berg M.P.: Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010, 121(20): 2169-2175.
33. Morales A., Painter T., Li R., Siegfried J.D., Li D., Norton N., Hershberger R.E.: Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010, 121(20): 2176-2182.
34. Murali S., Baldisseri M.R.: Peripartum cardiomyopathy. Critical Care Medicine 2005, 33(10 Suppl.): S340-346.
35. Podewski E.K., Hilfiker-Kleiner D., Hilfiker A., Morawietz H., Lichtenberg A., Wollert K.C., Drexler H.: Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 2003, 107(6): 798-802.
36. Veille J.C.: Peripartum cardiomyopathies: a review. American Journal of Obstetrics and Gynecology 1984, 148: 805.
37. Homans D.: Peripartum cardiomyopathy. N. Engl. J. Med. 1984, 312: 1432.
38. Mendelson M.: Postpartum cardiomyopathy associated with maternal cocaine abuse. The American Journal of Cardiology 1992, 70: 1092.
39. Lampert M.B., Hibbard J., Weinert L. et al.: Peripartum heart failure associated with prolonged tocolytic therapy. American Journal of Obstetrics and Gynecology 1993, 168: 493.
40. Kothari S.: Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? International Journal of Cardiology 1997, 60: 111.
41. Cenac A., Simonoff M., Moretto P., Djibo A.: A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. International Journal of Cardiology 1992, 36: 57.
42. Fett J.D., Ansari A.A., Sundstrom J.B., Combs G.F.: Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. International Journal of Cardiology 2002, 86(2-3): 311-316.
43. Sanderson J.E., Adesanya C.O., Anjorin F.I., Parry E.H.: Postpartum cardiac failure – heart failure due to volume overload? American Heart Journal 1979, 97(5): 613-621.
44. Lee W.: Clinical management of gravid women with peripartum cardiomyopathy. Obstetrics and Gynecology Clinics of North America 1991, 18(2): 257-271.
45. Katz R., Karliner J.S., Resnik R.: Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978, 58(3 Pt 1): 434-441.
46. Manolio T., Baughman K.L., Rodeheffer R. et al.: Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute workshop). The American Journal of Cardiology 1992, 69: 1458.
47. Forster O., Hilfiker-Kleiner D., Ansari A.A., Sundstrom J.B., Libhaber E., Tshani W., Becker A., Yip A., Klein G., Sliwa K.: Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. European Journal of Heart Failure 2008, 10(9): 861-868.
48. Fett J.: The role of MRI in peripartum cardiomyopathy. International Journal of Cardiology 2009, 137: 185.
49. Baruteau A.E., Leurent G., Martins R.P., Thebault C., Treguer F., Leclercq C., Daubert J.C., Mabo P.: Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. International Journal of Cardiology 2010, 144(1): 143-145.
50. Leurent G., Baruteau A.E., Larralde A., Ollivier R., Schleich J.M., Boulmier D., Bedossa M., Langella B., Le Breton H.: Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. International Journal of Cardiology 2009, 132(3): e91-93.
51. Kawano H., Tsuneto A., Koide Y., Tasaki H., Sueyoshi E., Sakamoto I., Hayashi T.: Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Internal Medicine 2008, 47(2): 97-102.
52. Caballero-Borrego J., Garcia-Pinilla J.M., Rueda-Calle E., de Teresa-Galvan E.: [Evidence of gadolinium late-enhancement on cardiac magnetic resonance imaging in a patient with peripartum cardiomyopathy]. Revista Espanola de Cardiologia 2008, 61(2): 219-220.
53. Mouquet F., Lions C., de Groote P., Bouabdallaoui N., Willoteaux S., Dagorn J., Deruelle P., Lamblin N., Bauters C., Beregi J.P.: Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. European Radiology 2008, 18(12): 2765-2769.
54. Marmursztejn J., Vignaux O., Goffinet F., Cabanes L., Duboc D.: Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. International Journal of Cardiology 2009, 137(3): e63-64.
55. Barone-Rochette G., Rodiere M., Lantuejoul S.: Value of cardiac MRI in peripartum cardiomyopathy. Archives of Cardiovascular Diseases 2011, 104(4): 263-264.
56. Sliwa K., Hilfiker-Kleiner D., Petrie M.C., Mebazaa A., Pieske B., Buchmann E., Regitz-Zagrosek V., Schaufelberger M., Tavazzi L., van Veldhuisen D.J. et al.: Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure 2010, 12(8): 767-778.
57. Isezuo S.A., Abubakar S.A.: Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethnicity & Disease 2007, 17(2): 228-233.
58. Walsh J.J., Burch G.E., Black W.C., Ferrans V.J., Hibbs R.G.: Idiopathic Myocardiopathy of the Puerperium (Postpartal Heart Disease). Circulation 1965, 32: 19-31.
59. Mason J.W., O’Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., Moon T.E.: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 1995, 333(5): 269-275.
60. Bozkurt B., Villaneuva F.S., Holubkov R., Tokarczyk T., Alvarez R.J. Jr., MacGowan G.A., Murali S., Rosenblum W.D., Feldman A.M., McNamara D.M.: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. Journal of the American College of Cardiology 1999, 34(1): 177-180.
61. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J.P., Becker A., McMurray J., Yamac H., Labidi S., Struman I. et al.: Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010, 121(13): 1465-1473.
62. Hilfiker-Kleiner D., Meyer G.P., Schieffer E., Goldmann B., Podewski E., Struman I., Fischer P., Drexler H.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. Journal of the American College of Cardiology 2007, 50(24): 2354-2355.
63. Habedank D., Kuhnle Y., Elgeti T., Dudenhausen J.W., Haverkamp W., Dietz R.: Recovery from peripartum cardiomyopathy after treatment with bromocriptine. European Journal of Heart Failure 2008, 10(11): 1149-1151.
64. Elkayam U., Goland S.: Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation 2010, 121(13): 1463-1464.
65. Keogh A., Macdonald P., Spratt P., Marshman D., Larbalestier R., Kaan A.: Outcome in peripartum cardiomyopathy after heart transplantation. The Journal of Heart and Lung Transplantation 1994, 13(2): 202-207.
66. Felker G.M., Jaeger C.J., Klodas E., Thiemann D.R., Hare J.M., Hruban R.H., Kasper E.K., Baughman K.L.: Myocarditis and long-term survival in peripartum cardiomyopathy. American Heart Journal 2000, 140(5): 785-791.
67. Rickenbacher P.R., Rizeq M.N., Hunt S.A., Billingham M.E., Fowler M.B.: Long-term outcome after heart transplantation for peripartum cardiomyopathy. American Heart Journal 1994, 127(5): 1318-1323.
68. Zimmerman H., Bose R., Smith R., Copeland J.G.: Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. The Annals of Thoracic Surgery 2010, 89(4): 1211-1217.
69. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., Baughman K.L., Kasper E.K.: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 2000, 342(15): 1077-1084.
70. Ravikishore A.G., Kaul U.A., Sethi K.K., Khalilullah M.: Peripartum cardiomyopathy: prognostic variables at initial evaluation. International Journal of Cardiology 1991, 32(3): 377-380.
71. Witlin A.G., Mabie W.C., Sibai B.M.: Peripartum cardiomyopathy: an ominous diagnosis. American Journal of Obstetrics and Gynecology 1997, 176(1 Pt 1): 182-188.
72. Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., Lang R.M.: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. American Journal of Obstetrics and Gynecology 1997, 176(1 Pt 1): 189-195.
73. Amos A.M., Jaber W.A., Russell S.D.: Improved outcomes in peripartum cardiomyopathy with contemporary. American Heart Journal 2006, 152(3): 509-513.
74. Chapa J.B., Heiberger H.B., Weinert L., Decara J., Lang R.M., Hibbard J.U.: Prognostic value of echocardiography in peripartum cardiomyopathy. Obstetrics and Gynecology 2005, 105(6): 1303-1308.
75. Hu C.L., Li Y.B., Zou Y.G., Zhang J.M., Chen J.B., Liu J., Tang Y.H., Tang Q.Z., Huang C.X.: Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007, 93(4): 488-490.
76. Dorbala S., Brozena S., Zeb S., Galatro K., Homel P., Ren J.F., Chaudhry F.A.: Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. Journal of the American Society of Echocardiography 2005, 18(1): 45-48.
77. Goland S., Bitar F., Modi K., Safirstein J., Ro A., Mirocha J., Khatri N., Elkayam U.: Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. Journal of Cardiac Failure 2011, 17(5): 426-430.
78. Goland S., Modi K., Bitar F., Janmohamed M., Mirocha J.M., Czer L.S., Illum S., Hatamizadeh P., Elkayam U.: Clinical profile and predictors of complications in peripartum cardiomyopathy. Journal of Cardiac Failure 2009, 15(8): 645-650.
79. Elkayam U., Tummala P.P., Rao K., Akhter M.W., Karaalp I.S., Wani O.R., Hameed A., Gviazda I., Shotan A.: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med. 2001, 344(21): 1567-1571.
80. Sutton M.S., Cole P., Plappert M., Saltzman D., Goldhaber S.: Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. American Heart Journal 1991, 121(6 Pt 1): 1776-1778.
81. Sliwa K., Forster O., Zhanje F., Candy G., Kachope J., Essop R.: Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. The American Journal of Cardiology 2004, 93(11): 1441-1443, A1410.
82. Fett J.D., Christie L.G., Murphy J.G.: Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Annals of Internal Medicine 2006, 145(1): 30-34.
2. Hull E., Hafkesbring E.: Toxic postpartal heart disease. New Orleans Med. Surg. J. 1937, 89: 550.
3. Sliwa K., Fett J., Elkayam U.: Peripartum cardiomyopathy. Lancet 2006, 368(9536): 687-693.
4. Demakis J.G., Rahimtoola S.H., Sutton G.C., Meadows W.R., Szanto P.B., Tobin J.R., Gunnar R.M.: Natural course of peripartum cardiomyopathy. Circulation 1971, 44(6): 1053-1061.
5. Pearson G.D., Veille J.C., Rahimtoola S., Hsia J., Oakley C.M., Hosenpud J.D., Ansari A., Baughman K.L.: Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000, 283(9): 1183-1188.
6. Hibbard J.U., Lindheimer M., Lang R.M.: A modified definition for peripartum cardiomyopathy and prognosis based on echocardiography. Obstetrics and Gynecology 1999, 94(2): 311-316.
7. Elkayam U., Akhter M.W., Singh H., Khan S., Bitar F., Hameed A., Shotan A.: Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 2005, 111(16): 2050-2055.
8. Seftel H., Susser M.: Maternity and myocardial failure in African women. British Heart Journal 1961, 23: 43-52.
9. Davidson N.M., Parry E.H.: The etiology of peripartum cardiac failure. American Heart Journal 1979, 97(4): 535-536.
10. Woolford R.M.: Postpartum myocardosis. Ohio medicine: journal of the Ohio State Medical Association 1952, 48(10): 924-930.
11. Pierce J.A., Price B.O., Joyce J.W.: Familial occurrence of postpartal heart failure. Archives of Internal Medicine 1963, 111: 651-655.
12. Sliwa K., Damasceno A., Mayosi B.M.: Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005, 112(23): 3577-3583.
13. Lampert M.B., Lang R.M.: Peripartum cardiomyopathy. American Heart Journal 1995, 130(4): 860-870.
14. Fett J.D., Christie L.G., Carraway R.D., Murphy J.G.: Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clinic proceedings Mayo Clinic 2005, 80(12): 1602-1606.
15. King T.M., Whitehorn W.V., Reeves B., Kubota R.: Effects of estrogen on composition and function of cardiac muscle. The American Journal of Physiology 1959, 196(6): 1282-1285.
16. Ueland K., Parer J.T.: Effects of estrogens on the cardiovascular system of the ewe. American Journal of Obstetrics and Gynecology 1966, 96(3): 400-406.
17. Schaible T.F., Malhotra A., Ciambrone G., Scheuer J.: The effects of gonadectomy on left ventricular function and cardiac contractile proteins in male and female rats. Circulation Research 1984, 54(1): 38-49.
18. Bryant E.E., Douglas B.H., Ashburn A.D.: Circulatory changes following prolactin administration. American Journal of Obstetrics and Gynecology 1973, 115(1): 53-57.
19. Sliwa K., Skudicky D., Bergemann A., Candy G., Puren A., Sareli P.: Peripartum cardiomyopathy: analysis of clinical outcome, left ventricular function, plasma levels of cytokines and Fas/APO-1. Journal of the American College of Cardiology 2000, 35(3): 701-705.
20. Sliwa K., Forster O., Libhaber E., Fett J.D., Sundstrom J.B., Hilfiker-Kleiner D., Ansari A.A.: Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. European Heart Journal 2006, 27(4): 441-446.
21. Hilfiker-Kleiner D., Kaminski K., Podewski E., Bonda T., Schaefer A., Sliwa K., Forster O., Quint A., Landmesser U., Doerries C. et al.: A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 2007, 128(3): 589-600.
22. Melvin K.R., Richardson P.J., Olsen E.G., Daly K., Jackson G.: Peripartum cardiomyopathy due to myocarditis. N. Engl. J. Med. 1982, 307(12): 731-734.
23. Sanderson J.E., Olsen E.G., Gatei D.: Peripartum heart disease: an endomyocardial biopsy study. British Heart Journal 1986, 56(3): 285-291.
24. O’Connell J.B., Costanzo-Nordin M.R., Subramanian R., Robinson J.A., Wallis D.E., Scanlon P.J., Gunnar R.M.: Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics. Journal of the American College of Cardiology 1986, 8(1): 52-56.
25. Midei M.G., DeMent S.H., Feldman A.M., Hutchins G.M., Baughman K.L.: Peripartum myocarditis and cardiomyopathy. Circulation 1990, 81(3): 922-928.
26. Bultmann B.D., Klingel K., Nabauer M., Wallwiener D., Kandolf R.: High prevalence of viral genomes and inflammation in peripartum cardiomyopathy. American Journal of Obstetrics and Gynecology 2005, 193(2): 363-365.
27. Rizeq M.N., Rickenbacher P.R., Fowler M.B., Billingham M.E.: Incidence of myocarditis in peripartum cardiomyopathy. The American Journal of Cardiology 1994, 74(5): 474-477.
28. Nelson J.L.: Pregnancy, persistent microchimerism, and autoimmune disease. Journal of the American Medical Women’s Association 1998, 53(1): 31-32, 47.
29. Ansari A.A., Fett J.D., Carraway R.E., Mayne A.E., Onlamoon N., Sundstrom J.B.: Autoimmune mechanisms as the basis for human peripartum cardiomyopathy. Clinical Reviews in Allergy & Immunology 2002, 23(3): 301-324.
30. Cenac A., Beaufils H., Soumana I., Vetter J.M., Devillechabrolle A., Moulias R.: Absence of humoral autoimmunity in peripartum cardiomyopathy. A comparative study in Niger. International Journal of Cardiology 1990, 26(1): 49-52.
31. Pearl W.: Familial occurrence of peripartum cardiomyopathy. American Heart Journal 1995, 129(2): 421-422.
32. van Spaendonck-Zwarts K.Y., van Tintelen J.P., van Veldhuisen D.J., van der Werf R., Jongbloed J.D., Paulus W.J., Dooijes D., van den Berg M.P.: Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy. Circulation 2010, 121(20): 2169-2175.
33. Morales A., Painter T., Li R., Siegfried J.D., Li D., Norton N., Hershberger R.E.: Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 2010, 121(20): 2176-2182.
34. Murali S., Baldisseri M.R.: Peripartum cardiomyopathy. Critical Care Medicine 2005, 33(10 Suppl.): S340-346.
35. Podewski E.K., Hilfiker-Kleiner D., Hilfiker A., Morawietz H., Lichtenberg A., Wollert K.C., Drexler H.: Alterations in Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signaling in patients with end-stage dilated cardiomyopathy. Circulation 2003, 107(6): 798-802.
36. Veille J.C.: Peripartum cardiomyopathies: a review. American Journal of Obstetrics and Gynecology 1984, 148: 805.
37. Homans D.: Peripartum cardiomyopathy. N. Engl. J. Med. 1984, 312: 1432.
38. Mendelson M.: Postpartum cardiomyopathy associated with maternal cocaine abuse. The American Journal of Cardiology 1992, 70: 1092.
39. Lampert M.B., Hibbard J., Weinert L. et al.: Peripartum heart failure associated with prolonged tocolytic therapy. American Journal of Obstetrics and Gynecology 1993, 168: 493.
40. Kothari S.: Aetiopathogenesis of peripartum cardiomyopathy: prolactin-selenium interaction? International Journal of Cardiology 1997, 60: 111.
41. Cenac A., Simonoff M., Moretto P., Djibo A.: A low plasma selenium is a risk factor for peripartum cardiomyopathy. A comparative study in Sahelian Africa. International Journal of Cardiology 1992, 36: 57.
42. Fett J.D., Ansari A.A., Sundstrom J.B., Combs G.F.: Peripartum cardiomyopathy: a selenium disconnection and an autoimmune connection. International Journal of Cardiology 2002, 86(2-3): 311-316.
43. Sanderson J.E., Adesanya C.O., Anjorin F.I., Parry E.H.: Postpartum cardiac failure – heart failure due to volume overload? American Heart Journal 1979, 97(5): 613-621.
44. Lee W.: Clinical management of gravid women with peripartum cardiomyopathy. Obstetrics and Gynecology Clinics of North America 1991, 18(2): 257-271.
45. Katz R., Karliner J.S., Resnik R.: Effects of a natural volume overload state (pregnancy) on left ventricular performance in normal human subjects. Circulation 1978, 58(3 Pt 1): 434-441.
46. Manolio T., Baughman K.L., Rodeheffer R. et al.: Prevalence and etiology of idiopathic dilated cardiomyopathy (summary of a National Heart, Lung and Blood Institute workshop). The American Journal of Cardiology 1992, 69: 1458.
47. Forster O., Hilfiker-Kleiner D., Ansari A.A., Sundstrom J.B., Libhaber E., Tshani W., Becker A., Yip A., Klein G., Sliwa K.: Reversal of IFN-gamma, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. European Journal of Heart Failure 2008, 10(9): 861-868.
48. Fett J.: The role of MRI in peripartum cardiomyopathy. International Journal of Cardiology 2009, 137: 185.
49. Baruteau A.E., Leurent G., Martins R.P., Thebault C., Treguer F., Leclercq C., Daubert J.C., Mabo P.: Peripartum cardiomyopathy in the era of cardiac magnetic resonance imaging: first results and perspectives. International Journal of Cardiology 2010, 144(1): 143-145.
50. Leurent G., Baruteau A.E., Larralde A., Ollivier R., Schleich J.M., Boulmier D., Bedossa M., Langella B., Le Breton H.: Contribution of cardiac MRI in the comprehension of peripartum cardiomyopathy pathogenesis. International Journal of Cardiology 2009, 132(3): e91-93.
51. Kawano H., Tsuneto A., Koide Y., Tasaki H., Sueyoshi E., Sakamoto I., Hayashi T.: Magnetic resonance imaging in a patient with peripartum cardiomyopathy. Internal Medicine 2008, 47(2): 97-102.
52. Caballero-Borrego J., Garcia-Pinilla J.M., Rueda-Calle E., de Teresa-Galvan E.: [Evidence of gadolinium late-enhancement on cardiac magnetic resonance imaging in a patient with peripartum cardiomyopathy]. Revista Espanola de Cardiologia 2008, 61(2): 219-220.
53. Mouquet F., Lions C., de Groote P., Bouabdallaoui N., Willoteaux S., Dagorn J., Deruelle P., Lamblin N., Bauters C., Beregi J.P.: Characterisation of peripartum cardiomyopathy by cardiac magnetic resonance imaging. European Radiology 2008, 18(12): 2765-2769.
54. Marmursztejn J., Vignaux O., Goffinet F., Cabanes L., Duboc D.: Delayed-enhanced cardiac magnetic resonance imaging features in peripartum cardiomyopathy. International Journal of Cardiology 2009, 137(3): e63-64.
55. Barone-Rochette G., Rodiere M., Lantuejoul S.: Value of cardiac MRI in peripartum cardiomyopathy. Archives of Cardiovascular Diseases 2011, 104(4): 263-264.
56. Sliwa K., Hilfiker-Kleiner D., Petrie M.C., Mebazaa A., Pieske B., Buchmann E., Regitz-Zagrosek V., Schaufelberger M., Tavazzi L., van Veldhuisen D.J. et al.: Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure 2010, 12(8): 767-778.
57. Isezuo S.A., Abubakar S.A.: Epidemiologic profile of peripartum cardiomyopathy in a tertiary care hospital. Ethnicity & Disease 2007, 17(2): 228-233.
58. Walsh J.J., Burch G.E., Black W.C., Ferrans V.J., Hibbs R.G.: Idiopathic Myocardiopathy of the Puerperium (Postpartal Heart Disease). Circulation 1965, 32: 19-31.
59. Mason J.W., O’Connell J.B., Herskowitz A., Rose N.R., McManus B.M., Billingham M.E., Moon T.E.: A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators. N. Engl. J. Med. 1995, 333(5): 269-275.
60. Bozkurt B., Villaneuva F.S., Holubkov R., Tokarczyk T., Alvarez R.J. Jr., MacGowan G.A., Murali S., Rosenblum W.D., Feldman A.M., McNamara D.M.: Intravenous immune globulin in the therapy of peripartum cardiomyopathy. Journal of the American College of Cardiology 1999, 34(1): 177-180.
61. Sliwa K., Blauwet L., Tibazarwa K., Libhaber E., Smedema J.P., Becker A., McMurray J., Yamac H., Labidi S., Struman I. et al.: Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 2010, 121(13): 1465-1473.
62. Hilfiker-Kleiner D., Meyer G.P., Schieffer E., Goldmann B., Podewski E., Struman I., Fischer P., Drexler H.: Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. Journal of the American College of Cardiology 2007, 50(24): 2354-2355.
63. Habedank D., Kuhnle Y., Elgeti T., Dudenhausen J.W., Haverkamp W., Dietz R.: Recovery from peripartum cardiomyopathy after treatment with bromocriptine. European Journal of Heart Failure 2008, 10(11): 1149-1151.
64. Elkayam U., Goland S.: Bromocriptine for the treatment of peripartum cardiomyopathy. Circulation 2010, 121(13): 1463-1464.
65. Keogh A., Macdonald P., Spratt P., Marshman D., Larbalestier R., Kaan A.: Outcome in peripartum cardiomyopathy after heart transplantation. The Journal of Heart and Lung Transplantation 1994, 13(2): 202-207.
66. Felker G.M., Jaeger C.J., Klodas E., Thiemann D.R., Hare J.M., Hruban R.H., Kasper E.K., Baughman K.L.: Myocarditis and long-term survival in peripartum cardiomyopathy. American Heart Journal 2000, 140(5): 785-791.
67. Rickenbacher P.R., Rizeq M.N., Hunt S.A., Billingham M.E., Fowler M.B.: Long-term outcome after heart transplantation for peripartum cardiomyopathy. American Heart Journal 1994, 127(5): 1318-1323.
68. Zimmerman H., Bose R., Smith R., Copeland J.G.: Treatment of peripartum cardiomyopathy with mechanical assist devices and cardiac transplantation. The Annals of Thoracic Surgery 2010, 89(4): 1211-1217.
69. Felker G.M., Thompson R.E., Hare J.M., Hruban R.H., Clemetson D.E., Howard D.L., Baughman K.L., Kasper E.K.: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 2000, 342(15): 1077-1084.
70. Ravikishore A.G., Kaul U.A., Sethi K.K., Khalilullah M.: Peripartum cardiomyopathy: prognostic variables at initial evaluation. International Journal of Cardiology 1991, 32(3): 377-380.
71. Witlin A.G., Mabie W.C., Sibai B.M.: Peripartum cardiomyopathy: an ominous diagnosis. American Journal of Obstetrics and Gynecology 1997, 176(1 Pt 1): 182-188.
72. Lampert M.B., Weinert L., Hibbard J., Korcarz C., Lindheimer M., Lang R.M.: Contractile reserve in patients with peripartum cardiomyopathy and recovered left ventricular function. American Journal of Obstetrics and Gynecology 1997, 176(1 Pt 1): 189-195.
73. Amos A.M., Jaber W.A., Russell S.D.: Improved outcomes in peripartum cardiomyopathy with contemporary. American Heart Journal 2006, 152(3): 509-513.
74. Chapa J.B., Heiberger H.B., Weinert L., Decara J., Lang R.M., Hibbard J.U.: Prognostic value of echocardiography in peripartum cardiomyopathy. Obstetrics and Gynecology 2005, 105(6): 1303-1308.
75. Hu C.L., Li Y.B., Zou Y.G., Zhang J.M., Chen J.B., Liu J., Tang Y.H., Tang Q.Z., Huang C.X.: Troponin T measurement can predict persistent left ventricular dysfunction in peripartum cardiomyopathy. Heart 2007, 93(4): 488-490.
76. Dorbala S., Brozena S., Zeb S., Galatro K., Homel P., Ren J.F., Chaudhry F.A.: Risk stratification of women with peripartum cardiomyopathy at initial presentation: a dobutamine stress echocardiography study. Journal of the American Society of Echocardiography 2005, 18(1): 45-48.
77. Goland S., Bitar F., Modi K., Safirstein J., Ro A., Mirocha J., Khatri N., Elkayam U.: Evaluation of the clinical relevance of baseline left ventricular ejection fraction as a predictor of recovery or persistence of severe dysfunction in women in the United States with peripartum cardiomyopathy. Journal of Cardiac Failure 2011, 17(5): 426-430.
78. Goland S., Modi K., Bitar F., Janmohamed M., Mirocha J.M., Czer L.S., Illum S., Hatamizadeh P., Elkayam U.: Clinical profile and predictors of complications in peripartum cardiomyopathy. Journal of Cardiac Failure 2009, 15(8): 645-650.
79. Elkayam U., Tummala P.P., Rao K., Akhter M.W., Karaalp I.S., Wani O.R., Hameed A., Gviazda I., Shotan A.: Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med. 2001, 344(21): 1567-1571.
80. Sutton M.S., Cole P., Plappert M., Saltzman D., Goldhaber S.: Effects of subsequent pregnancy on left ventricular function in peripartum cardiomyopathy. American Heart Journal 1991, 121(6 Pt 1): 1776-1778.
81. Sliwa K., Forster O., Zhanje F., Candy G., Kachope J., Essop R.: Outcome of subsequent pregnancy in patients with documented peripartum cardiomyopathy. The American Journal of Cardiology 2004, 93(11): 1441-1443, A1410.
82. Fett J.D., Christie L.G., Murphy J.G.: Brief communication: Outcomes of subsequent pregnancy after peripartum cardiomyopathy: a case series from Haiti. Annals of Internal Medicine 2006, 145(1): 30-34.